Hiran Orgochem Ltd has been delisted from the stock exchange.
Sector
PharmaceuticalsOpen
₹0.44Prev. Close
₹0.46Turnover(Lac.)
₹0.12Day's High
₹0.48Day's Low
₹0.4452 Week's High
₹052 Week's Low
₹0Book Value
₹-6.22Face Value
₹10Mkt Cap (₹ Cr.)
4.74P/E
5.33EPS
0.09Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Equity Capital | 98.66 | 98.66 | 98.66 | 98.66 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -161.02 | -133.26 | -126.04 | -66.03 |
Net Worth | -62.36 | -34.6 | -27.38 | 32.63 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Revenue | 0.42 | 2.64 | 23.96 | 38.93 |
yoy growth (%) | -84.03 | -88.96 | -38.44 | -73.66 |
Raw materials | -0.42 | -2.54 | -22.8 | -36.84 |
As % of sales | 99.89 | 96.03 | 95.16 | 94.63 |
Employee costs | -0.13 | -0.11 | -0.75 | -1.57 |
| Y/e 31 Mar( In .Cr) | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Profit before tax | -27.75 | -7.21 | -60.01 | -9.09 |
Depreciation | -0.05 | -1.5 | -2.77 | -2.75 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | -12.04 | -8.71 | -57.42 | -12.84 |
Other operating items |
| Y/e 31 Mar | Mar-2015 | Mar-2014 | Jun-2013 | Jun-2012 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -84.03 | -88.96 | -38.44 | -73.66 |
Op profit growth | 343.53 | -89.01 | 373.82 | -81.71 |
EBIT growth | 294.57 | -88.26 | 733.07 | -89.36 |
Net profit growth | 284.66 | -87.97 | 559.82 | -89.09 |
| Particulars (Rupees in Crores.) | Mar-2016 | Mar-2015 |
|---|---|---|
Gross Sales | 0 | 0.42 |
Excise Duty | 0 | 0 |
Net Sales | 0 | 0.42 |
Other Operating Income | 0 | 0 |
Other Income | 0.93 | 0.81 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,845 | 147.13 | 4,41,609.6 | 608.7 | 0.87 | 4,887.27 | 93.23 |
Divis Laboratories Ltd DIVISLAB | 6,797.7 | 67.34 | 1,79,278.9 | 756 | 0.44 | 2,793 | 629.49 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,540.9 | 67.12 | 1,50,648.83 | 467 | 0 | 2,677 | 249.73 |
Cipla Ltd CIPLA | 1,418.2 | 30.93 | 1,14,469.38 | 384.64 | 0.92 | 3,840.92 | 423.38 |
Dr Reddys Laboratories Ltd DRREDDY | 1,319.05 | 34.46 | 1,10,955.12 | -219.4 | 0.6 | 3,802.6 | 375.78 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
KANTILAL MANGALCHAND HIRAN
Additional Director
DARIYADEVI KANTILAL HIRAN
Director
HIRACHAND NEMICHAND BAFNA
Director
NITINN SATYENDRA GUPTA
908 9th Flr Off LinkRd Malad(W,
Market CSL Raheja Metroplex,
Maharashtra - 400064
Tel: 91-022-40144127
Website: http://www.hiranorgochem.com
Email: info@hiranorgochem.com
E-2/3 Ansa Indl Est,
Saki Vihar Road, Sakinaka Andheri(E),
Mumbai - 400072
Tel: 91-22-40430200/28470
Website: www.bigshareonline.com
Email: investor@bigshareonline.com
Summary
Hiran Orgochem Ltd., the Mumbai based company, is into manufacture of bulk drugs like Ciprofloxacian, Hydrochloride -USP. The companys plant at Panoli has an installed capacity of 240000 KGS.
Read More
Reports by Hiran Orgochem Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.